Literature DB >> 15833469

Common symptoms in advanced cancer.

Ruth L Lagman1, Mellar P Davis, Susan B LeGrand, Declan Walsh.   

Abstract

The key points of this article are anorexia and cachexia are: A major cause of cancer deaths. Several drugs are available to treat anorexia and cachexia. Dyspnea in cancer usually is caused by several factors. Treatment consists of reversing underlying causes, empiric bronchodilators, cortico-steroids--and in the terminally ill patients-opioids, benzodiazepines,and chlorpromazine. Delirium is associated with advanced cancer. Empiric treatment with neuroleptics while evaluating for reversible causes is a reasonable approach to management. Nausea and vomiting are caused by extra-abdominal factors (drugs,electrolyte abnormalities, central nervous system metastases) or intra-abdominal factors (gastroparesis, ileus, gastric outlet obstruction, bowel obstruction). The pattern of nausea and vomiting differs depending upon whether the cause is extra- or intra-abdominal. Reversible causes should be sought and empiric metoclopramide or haloperidol should be initiated. Fatigue may be caused by anemia, depression, endocrine abnormalities,or electrolyte disturbances that should be treated before using empiric methylphenidate. Constipation should be treated with laxatives and stool softeners. Both should start with the first opioid dose.

Entities:  

Mesh:

Year:  2005        PMID: 15833469     DOI: 10.1016/j.suc.2004.11.004

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  8 in total

Review 1.  Treatment of gastric outlet obstruction that results from unresectable gastric cancer: Current evidence.

Authors:  Yasuhiro Miyazaki; Shuji Takiguchi; Tsuyoshi Takahashi; Yukinori Kurokawa; Tomoki Makino; Makoto Yamasaki; Kiyokazu Nakajima; Masaki Mori; Yuichiro Doki
Journal:  World J Gastrointest Endosc       Date:  2016-02-10

2.  The relationship between dyspnea and patient satisfaction with quality of life in advanced cancer.

Authors:  Digant Gupta; Christopher G Lis; James F Grutsch
Journal:  Support Care Cancer       Date:  2006-11-21       Impact factor: 3.603

3.  Can anorexia predict patient satisfaction with quality of life in advanced cancer?

Authors:  Christopher G Lis; Digant Gupta; James F Grutsch
Journal:  Support Care Cancer       Date:  2008-04-02       Impact factor: 3.603

4.  CXCR4 receptors in the dorsal medulla: implications for autonomic dysfunction.

Authors:  Gerlinda E Hermann; Montina J Van Meter; Richard C Rogers
Journal:  Eur J Neurosci       Date:  2008-02       Impact factor: 3.386

5.  GALNT14 genotype, α-fetoprotein and therapeutic side effects predict post-chemotherapy survival in patients with advanced hepatocellular carcinoma.

Authors:  Wey-Ran Lin; Chao-Wei Hsu; Yi-Cheng Chen; Ming-Ling Chang; Kung-Hao Liang; Ya-Hui Huang; Chau-Ting Yeh
Journal:  Mol Clin Oncol       Date:  2014-05-15

6.  Symptom burden of adults with type 2 diabetes across the disease course: diabetes & aging study.

Authors:  Rebecca L Sudore; Andrew J Karter; Elbert S Huang; Howard H Moffet; Neda Laiteerapong; Yael Schenker; Alyce Adams; Rachel A Whitmer; Jennifer Y Liu; Yinghui Miao; Priya M John; Dean Schillinger
Journal:  J Gen Intern Med       Date:  2012-08-02       Impact factor: 5.128

7.  Methylnaltrexone in the treatment of opioid-induced constipation.

Authors:  Beverley Greenwood-Van Meerveld; Kelly M Standifer
Journal:  Clin Exp Gastroenterol       Date:  2008-12-14

8.  Predicting survival in cancer patients with and without 30-day readmission of an unplanned hospitalization using a deficit accumulation approach.

Authors:  Timothy N Hembree; Sarah Thirlwell; Richard R Reich; Smitha Pabbathi; Martine Extermann; Asha Ramsakal
Journal:  Cancer Med       Date:  2019-09-07       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.